Market closedNon-fractional
Conmed/CNMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Conmed
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
Ticker
CNMD
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Equipment and Supplies
Headquarters
Largo, United States
Employees
4,000
Website
www.conmed.com
Conmed Metrics
BasicAdvanced
$2.2B
Market cap
27.50
P/E ratio
$2.60
EPS
1.42
Beta
$0.80
Dividend rate
1.12%
Dividend yield
Price and volume
Market cap
$2.2B
Beta
1.42
Dividend rate
$0.80
Financial strength
Current ratio
2.182
Quick ratio
0.945
Long term debt to equity
115.848
Total debt to equity
115.929
Dividend payout ratio (TTM)
29.82%
Interest coverage (TTM)
3.82%
Management effectiveness
Return on assets (TTM)
3.68%
Return on equity (TTM)
10.25%
Valuation
Price to earnings (TTM)
27.499
Price to revenue (TTM)
1.744
Price to book
2.56
Price to tangible book (TTM)
-3.69
Price to free cash flow (TTM)
15.552
Dividend yield (TTM)
1.12%
Growth
Revenue change (TTM)
14.83%
Earnings per share change (TTM)
-182.79%
3-year revenue growth (CAGR)
12.71%
3-year earnings per share growth (CAGR)
80.57%
What the Analysts think about Conmed
Analyst Ratings
Majority rating from 8 analysts.
Conmed Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$312M
-4.53%
Net income
$20M
-40.30%
Profit margin
6.31%
-37.46%
Conmed Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.83
$0.90
$1.06
$0.79
-
Expected
$0.79
$0.83
$1.11
$0.74
$0.91
Surprise
4.49%
8.43%
-4.50%
7.01%
-
Conmed News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Conmed stock?
Conmed (CNMD) has a market cap of $2.2B as of July 25, 2024.
What is the P/E ratio for Conmed stock?
The price to earnings (P/E) ratio for Conmed (CNMD) stock is 27.5 as of July 25, 2024.
Does Conmed stock pay dividends?
Yes, the Conmed (CNMD) stock pays dividends to shareholders. As of July 25, 2024, the dividend rate is $0.8 and the yield is 1.12%. Conmed has a payout ratio of 29.82% on a trailing twelve-month basis.
When is the next Conmed dividend payment date?
The next Conmed (CNMD) dividend payment date is unconfirmed.
What is the beta indicator for Conmed?
Conmed (CNMD) has a beta rating of 1.42. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Conmed stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.